文献速递胃肠外科

高危T1b食管腺癌哨兵淋巴结导航手术的可行性研究

Feasibility of sentinel node navigated surgery in high-risk T1b esophageal adenocarcinoma patients using a hybrid tracer of technetium-99 m and indocyanine green.
PubMed 文献 · Surg Endosc · 2021-05-27

这项前瞻性多中心预试验纳入5例高危T1b食管腺癌患者,术前在内镜下切除瘢痕周围注射锝-99m/吲哚菁绿/纳米胶体混合示踪剂,术前行淋巴显像/SPECT-CT,术中结合γ探头和荧光检测定位并切除哨兵淋巴结。所有患者均成功识别并切除哨兵淋巴结(中位3枚,范围2-7),术前与术中检测一致性高,荧光检测在2例中额外发现瘤周哨兵淋巴结,切除淋巴结均无微转移。结论认为该技术可行且安全,吲哚菁绿荧光具有附加价值。

要点

  • 混合示踪剂哨兵淋巴结导航手术在高危T1b食管腺癌中可行且安全。
  • 所有患者均成功识别并切除哨兵淋巴结,中位3枚(范围2-7)。
  • 吲哚菁绿荧光可额外发现瘤周哨兵淋巴结,具有附加价值。

核心结论

  • 使用锝-99m/吲哚菁绿/纳米胶体混合示踪剂的哨兵淋巴结导航手术在高危T1b食管腺癌患者中似乎可行且安全。
  • 吲哚菁绿荧光对检测瘤周哨兵淋巴结似乎具有附加价值。

研究设计与样本

  • 前瞻性、多中心预试验,纳入5例高危T1b食管腺癌患者。
  • 术前一天内镜下在切除瘢痕周围注射混合示踪剂,术前行淋巴显像/SPECT-CT,术中结合γ探头和荧光检测定位并切除哨兵淋巴结,随后行食管切除术。

主要发现

  • 所有患者均识别并切除哨兵淋巴结,中位3枚/患者(范围2-7)。
  • 术前与术中哨兵淋巴结检测一致性高。
  • 2例患者通过荧光检测额外发现瘤周哨兵淋巴结。
  • 切除的淋巴结均无(微)转移,手术切除标本中未检测到淋巴结转移。

临床怎么用

  • 该技术可能用于高危T1b食管腺癌患者,以 tailoring 淋巴结清扫范围。
  • 吲哚菁绿荧光检测有助于发现瘤周哨兵淋巴结。

局限性

  • 样本量小(5例),为预试验。
  • 能否优化食管切除术的选择需未来研究进一步探讨。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Minimally invasive esophagectomy with two-field lymphadenectomy is standard of care for T1b esophageal adenocarcinoma (EAC) with a high risk of lymph node metastasis. Sentinel node navigation surgery (SNNS) is a well-known concept to tailor the extent of lymphadenectomy. The aim of this study was to evaluate the feasibility and safety of SNNS with a hybrid tracer (technetium-99 m/indocyanine green/nanocolloid) for patients with high-risk T1b EAC. METHODS: In this prospective, multicenter pilot study, 5 patients with high-risk T1b EAC were included. The tracer was injected endoscopically around the endoscopic resection scar the day before surgery, followed by preoperative imaging (lymphoscintigraphy/SPECT-CT). During surgery, first the SNs were localized and resected based on preoperative imaging and intraoperative gammaprobe- and fluorescence-based detection, followed by esophagectomy. Primary endpoints were the percentage of patients with detectable SNs, concordance between preoperative and intraoperative SN detection, and the additive value of indocyanine green. RESULTS: SNs could be identified and resected in all patients (median 3 SNs per patient, range 2-7). There was a high concordance between preoperative and intraoperative SN detection. In 2 patients additional peritumoral SNs were identified with fluorescence-based detection. None of the resected lymph nodes showed signs of (micro)metastases and no nodal metastases were detected in the surgical resection specimen. CONCLUSIONS: SNNS using technetium-99 m/indocyanine green/nanocolloid seems feasible and safe in patients with high-risk T1b EAC. Indocyanine green fluorescence seems to be of additive value for detection of peritumoral SNs. Whether this approach can optimize selection for esophagectomy needs to be studied in future research.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Overwater A, Weusten BLAM, Ruurda JP, et al. Feasibility of sentinel node navigated surgery in high-risk T1b esophageal adenocarcinoma patients using a hybrid tracer of technetium-99 m and indocyanine green. Surg Endosc. 2021. PMID: 34046715. doi:10.1007/s00464-021-08551-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。